| Mepha Pharma AG - Cansartan-Mepha plus 16/12.5, Tabletten |
| 61215 | | 02 | | Cansartan-Mepha plus 16/12.5 | | Tabletten | | C09DA06 | | Candesartan and Diuretics | | 24.01.2011 | | |
|
| Composition |
| candesartanum cilexetilum 16.00 mg, hydrochlorothiazidum 12.50 mg, maydis amylum, lactosum monohydricum 109.30 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.43 mg, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Candesartanum Cilexetil | 16 mg | | Hydrochlorothiazide | 12.5 mg |
| | BAG: Active Agent | Dose |
|---|
| Candesartanum Cilexetil | 16 mg | | Hydrochlorothiazide | 12.5 mg |
| | | | Inactive agents | Dose |
|---|
| Carmellosum Natricum Conexum | | | Hydroxypropylcellulosum | | | Lactose Monohydrate | 109.3 mg | | Magnesii Stearas | | | Maydis Amylum | | | Pro Compresso | | | Triethylis Citras | |
| |
|
|
